Press Releases
Search by Year
-
11 May 2015
2014 Financial Results
Solid growth in sales: Up 8.7%, including BioFire and at constant exchange rates Up 3.8%, at constant exchange rates and scope of consolidation Contributive operating income before non-recurring items...
-
23 Apr 2015
bioMérieux - First-Quarter 2015 Business Review
Strong growth in sales €448 million in sales Up 20.8% as reported Up 8.7% at constant exchange rates and scope of consolidation Sales off to a fast start in the Americas, up 19.6%* Strengthened positi...
-
14 Apr 2015
BioFire dépose auprès de la FDA une demande de novo pour le panel FilmArray® Méningite - Encéphalite
Marcy l’Etoile, France - April 14, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its molecular biology affiliate, has submitted a de novo classi...
-
26 Feb 2015
BioFire Receives FDA Clearance for the FilmArray® 2.0 System
New system delivers higher throughput, single database management and minimized footprint Marcy l’Etoile, France – February 26, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, ...
-
10 Feb 2015
BioFire Defense, a bioMérieux Company, Receives Prestigious Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola Test
BioFire Defense, LLC is proud to announce that it is the recipient of the Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola test. The New Product Innovation Award is...
-
22 Jan 2015
bioMérieux and Astute Medical sign a global agreement to develop and market NephroCheck® Test for VIDAS®, an assay to assess the risk of developing acute kidney injury
Marcy l’Etoile, (France) - San Diego, California (United States) - January 22, 2015 - bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to ...
-
22 Jan 2015
Business Review for the Three Months and Full Year Ended December 31, 2014
Sales: solid growth, lifted sharply by BioFire Revenue: €1,698 million, up a reported 7% Up 8.7%, including BioFire and at constant exchange rates Up 3.8% at constant exchange rates and scope of conso...
-
09 Jan 2015
Strategic alliance between bioMérieux and COPAN to automate clinical microbiology laboratories and enhance their operational efficiency
bioMérieux distributes COPAN’s WASP® and WASPLab™ automated systems and speeds up deployment of its “FMLA® - Lab Efficiency” vision »...
-
18 Nov 2014
bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections
Marcy l’Etoile, France – San Diego, California, United States – November 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced...
-
27 Oct 2014
BioFire Defense, a bioMérieux company, receives fast-track authorization of FilmArray® Ebola Test
Marcy l’Etoile (France) - October 27, 2014 - BioFire Defense, LLC of Salt Lake City, UT announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) ...